EC Q4 2025 Earnings EPS Misses Estimates Amid Mixed Operational Performance NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds HG Q1 2026 Earnings Strong EPS Beat Amidst Market Skepticism Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline Itau Unibanco ITUB Q1 2026 Earnings EPS Misses Estimates as Net Income Falls Short of Expectations CBNA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction